no amount of hopium will get pphm over $1.00 anytime soon....nobody is buying this stock, just selling.....sad sad sad scam of the decade, but the shares will make nice wallpaper.......

Yes, PPHM soon to rule the BP world and even though they failed all trials...

Yes, that makes perfect sense.

Since retail owns PPHM stock 95%+ now, anyone buying here is an absolute genius....never mind the R3K funds are all selling and the PPS is .39c with 300m shares outstanding and no trials running, the FDA will approve Bavi because by gosh, they should approve a drug that has failed all trials just once and why not PPHM? yes,i but Nash approve it, soon.....l

It means PPHM is in great demand....will rule all BP's soon

Because it is all pre arranged trades negotiated weeks ago, same every time the clowns get kicked out, same as all other R3K stocks that got the boot....

No secret conspiracy theories as to who bought........

the same hand the last 3 times PPHM got dumped from the R3K, market makers......

no, sorry to say. No BP or Family bought them or owns any PPHM.

now the boys can go ahead with the RS now that all that is left is retail.

Sad state of affairs.


I know. getting booted from the R3K is a great thing. A BP bought all those shares and a deal is imminent....
Yeah, that's the ticket.

and the huge 1/20 RS will also be great news here.

all is going as plan and Bavi will rule the BP landscape, soon......real soon. as soon as the boys get those options

They have to buy and own to short....they aren't investing long....

Make that .38c stocks, lol

Institutions don't invest in .39c stocks......

I expect PPHM to go up with the rebalance, always did in the past and then shorted back later after another trial failure or some other PPHM self induced shot in the foot.

it's worth .39c.
soon a RS BTW 1/15 and 1/20

more.lilely it was out b4 Sunrise data and is now a non event. more likely imo.

The recently completed SUNRISE trial was a randomized phase 3 study of the same combination, but was closed for futility at interim analysis

Funny, NCCN didnt sugar coat it and PPHM paid them $2m to get trials and so far nobody has even applied for the grant?

Specific exclusions from this RFP include:•
Phase 3 studies
Studies in pediatric populations
Studies in unselected immunotherapy
naïve patient populations where
immunotherapy is already approved
(NSCLC,renal cancer, bladder cancer
melanoma)
Combination studies with chemotherapeutic agents;
Single agent studies unless the study is a proposed window study evaluating mechanistic endpoints utilizing multiple tumor biopsies

Studies evaluating bavituximab in combination with pembrolizumab in hepatocellular carcinoma

Proposals focusing solely on preclinical studies

http://cancer.ucsf.edu/intranet/sm_files/NCCN%20Bavituximab%20RFP.pdf

Yeah, no info on that front and
PPHM was paid huge to drop that ball, probably someone inside PPHM helping Fargo......Sunrise, PPHM flat out failed and people here believe PPHM mngnt's non sense wording in a pr yet they show no numbers?

Why any long that has been her 10 years or more believes any of that is shocking.........I don't believe anything they say or trust anything they do, they are grossly incompetent.

$3.00?
Wow, it gets better every day, last I looked it was .39c with no trials and A RS coming.

Oh, you meant $3.00 after a 1/20 RS and once it gets shorted back down, I get it...what was I thinking....

How many times have we heard this non sense about options and Russell shares going to a bidder?

At least every time they drop out of the Russell and every time the pps craters on another failed trial and then it is dilution dilution dilution followed by a RS

The game is up for sure, slowly retail is understanding PPHM is a scam and after 12 years of not even trying to increase the stock, it is almost impossible for PPHM to raise cash unless they RS and do a pipe, something they actually are really good at.


All this talk about buyouts and options and partnering?
Who wants to be partnered with a a drug that has failed every trial?

They will come out when Bavi fails I/O, not a day b4.
Since I/O hasn't even started yet, look for a massive RS b4 BB's come off the shelf so Bavi can take that shelf space, it is a crowded shelf, after all

$1.25 tops

Ok, what ever you say, you have convinced me....

Nope, and it will be sooner than most think.

Anyone thinks PPHM gives a rats arse about retail investors is delusional.

They will do a massive RS and still keep their jobs and pay.

Any deal possibilities will require a massive RS as no partner is going to pay up and bail out retail investors, ain't gonna happen.


The odds of a deal went down with the Sunset, now there are no trials and no data and a RS soon and not PPHM soon

Then a pipe, BB hopium and wash rinse repeat....

Only thing imminent is a 1/15 or 1/20 RS to get the pps up high enough to do a pipe one last time....

Sell? Buy all you want, nobody here cares, Tustin is Tustin, nobody there cares either.....

When your stock has 300m shares and trades at .39c, it smells like big things are coming?

Wow.......

lol, probably made up.

MDSC's are far from being proven in Human's so not many in Biotech are wasting their time on this after 30 years.

Again, if you cant cure mice, you are in the wrong business.

PPHM probably paid some co's to attend.

Efforts to combine bavituximab with docetaxel as a treatment for patients with stage IIIb/IV nonsquamous non–small cell lung cancer (NSCLC) faltered earlier this year when the phase III SUNRISE trial was halted after a futility analysis, according to Peregrine Pharmaceuticals, the company developing the drug. - See more at: http://www.onclive.com/web-exclusives/emerging-immunotherapy-target-in-spotlight-at-wistar?p=2#sthash.ApbILphB.dpuf

The investors should be embarrassed, SK is getting paid like a Fortune 500 CEO, why would he be embarrassed?

Investors were snookered.....

If you can't cure mice, you are in the wrong buzz.....
PPHM Data from mice to humans is a no go for Bavi.........

I am short since Dart bought at 1.08 and see no compelling reason to cover. RS is inevitable

they are short and not naked. they must own the shares to short

OH come now, there is a secret BLA, they'll be selling Bavi in 9 mnths or so, probably...or probably not, well yeah, not likely, but a nice fantasy.

Might as well start Cotara PHIII while we are at it......I mean why not two failed PHIII's?



At least we now know Cotara a s Bavi are both on the shelf.

Avid won't do squat for the pps as long as their is peregrine.

Good bet is to short it even at .40c.....RS coming, more dilution and more failed Bavi I/O trials and then wash rinse repeat with Betabodies......

Yeah pretty much.....it gets better everyday.
Almost as good as movie...

Lol, try a .40c stock, more dilution, kicked off of R3K and a RS coming, yes it is all good, except the data and the pps and Bavi.

Other than that, keep buying........good idea.....or not.....yeah, probably not.....

Yes, it sure looks astronomical....or not.
Probably not based on every trial to date except mice.
If you can cure mice, you are in the wrong business...

most here are so under water they have no choice but to believe.

if they asked their spouses and friends if they should love pphm they would all be told they are nuts.

Yeah, right. GILD Doesn't even know who PPHM is......silly....

lol. your endorsement is an endorsement to short pphm.

write another article, pls

Yeah, but it was fun for for 10 years to watch the pps and your share count go down the drain, good times.

Go PPHM.....Shish boom bah...

Just that Bavi doesn't work well enough or long enough to be a player in oncology...

The rest is just noise by the boys...

Yes, it's always sometimes later..
Actually, try never....nothing will happen except mfg now and a few failed PHiI I/o trials.

Asco was huge or is it 2017 ASCO?